Michael Przybilla

,

Credentials

PhD

Bio

Dr. Michael Przybilla is currently an Assistant Professor in the Department of Pediatrics, Division of Pediatric Genetics & Metabolism. He graduated from the University of Minnesota Twin Cities in 2012 with a BS in Biology. He received his PhD in Molecular, Cellular, Developmental Biology & Genetics at the University of Minnesota in 2018. From 2019-2022 he was a postdoctoral assistant in the Gene Therapy and Diagnostics Laboratory, working with Dr. Chester B. Whitley. His work focused on the development and characterization of murine models of lysosomal diseases and the development of novel therapies for such diseases. He joined the Department of Pediatrics Faculty in 2022.

Research Summary

Dr. Przybilla's research has focused on the development of animal models of lysosomal diseases and has progressed into the development and testing of novel therapies for such diseases including enzyme replacement therapy, small molecule chaperones, gene therapy, and gene editing. Currently, his research is focused on developing a gene therapy that can potentially serve as a platform technology to treat multiple lysosomal diseases. Additionally, Dr. Przybilla is collaborating with several research groups to test conduct preclinical studies for potential therapeutics for several lysosomal diseases.Interests include: Therapeutic development for genetic diseases, with a focus on lysosomal diseases.